• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION RESTORE ADVANCED; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION RESTORE ADVANCED; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF Back to Search Results
Model Number 37713
Device Problems Break (1069); High impedance (1291)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/01/2017
Event Type  Injury  
Manufacturer Narrative
Date of event: please note that this date is based off of the date that the article was accepted for publication as the event dates were not provided in the published literature.The device was used for an off label indication.Concomitant medical products: product id neu_unknown_lead, product type: lead.Product id neu_unknown_ext, product type: extension.
 
Event Description
De vloo, p., raymaekers, s., van kuyck, k., luyten, l., gabriels, l., nuttin, b.Rechargeable stimulators in deep brain stimulation for obsessive-compulsive disorder: a prospective interventional cohort study.Neuromodulation.2017.Doi: 10.1111/ner.12577.Summary: background: from 1999 onwards, deep brain stimulation (dbs) has been proposed as an alternative to capsulotomy in refractory cases of obsessive-compulsive disorder (ocd).Although rechargeable implantable pulse generators (ripgs) have been used extensively in dbs for movement disorders, there are no reports on ripgs in patients with a psychiatric dbs indication, and even possible objections to their use.Objective: we aim to evaluate ripgs in ocd in terms of effectiveness, applicability, safety, and need for ipg replacement.Methods: in this prospective before-after study recruiting from 2007 until 2012, ocd patients requiring at least one ipg replacement per 18 months were proposed to have a ripg implanted at the next ipg depletion.Ocd severity was the primary outcome.Ten patients were analyzed.Results: psychiatric symptoms and global functioning remained stable in the two years after as compared to the two years before ripg implantation.Over the same period, the prescribed ocd medication doses did not increase and the dbs stimulation parameters were largely unaltered.Until the end of the follow-up (mean 4 3/4 years; maximum seven years), the dbs-related surgery frequency decreased and there were no ripg replacements.During the first few weeks after implantation, two patients obsessively checked the ripg, but afterwards there were no signs of compulsively checking or recharging the ripg.Two patients experienced ripgoverdischarges (five occurrences in total).Conclusions: this is the first report on ripgs in dbs for ocd patients.The use of ripgs in this population appears to be effective, applicable, and safe and diminishes the need for ipg replacements.Reported events: 2.Patient 8: a (b)(6) (at implant) female patient with bilateral deep brain stimulation (dbs) for obsessive compulsive disorder (ocd) underwent unilateral electrode and extension wire revision due to breakage with high impedance over an electrode contact.It was not possible to ascertain specific device information from the article or to match the reported event with any previously reported event.
 
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESTORE ADVANCED
Type of Device
STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer Contact
lisa clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key6508529
MDR Text Key73327185
Report Number3007566237-2017-01516
Device Sequence Number1
Product Code MFR
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
H050003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/20/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number37713
Device Catalogue Number37713
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/23/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age28 YR
-
-